Alzamend Neuro PEG Ratio

Alzamend Neuro posts a PEG ratio of -5.11. That is above the Healthcare sector average of -5.81. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a PEG ratio near -5.81 is typical. Alzamend Neuro's -5.11 is higher that level. That is roughly 12.1% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Alzamend Neuro's PEG ratio of -5.11 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for ALZN's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -5.81), and (3) consistency with growth and profitability. This page covers the first two; Alzamend Neuro's other metric pages and overview cover the third.

Judging Alzamend Neuro against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in PEG ratio easier to interpret. Start with -5.11 here, then scan peer and history charts to see if the gap is persistent.